BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16045692)

  • 1. Muscarinic cholinergic receptors in the human melanoma cell line SK-Mel 28: modulation of chemotaxis.
    Boss A; Oppitz M; Lippert G; Drews U
    Clin Exp Dermatol; 2005 Sep; 30(5):557-64. PubMed ID: 16045692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
    Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
    Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of muscarinic receptors in the human melanoma cell line SK-Mel-28 via calcium mobilization.
    Noda S; Lammerding-Köppel M; Oettling G; Drews U
    Cancer Lett; 1998 Nov; 133(1):107-14. PubMed ID: 9929168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of muscarinic receptor subtypes on human cornea and conjunctiva.
    Liu S; Li J; Tan DT; Beuerman RW
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2987-96. PubMed ID: 17591863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cellular contractions in the human melanoma cell line SK-mel 28 after muscarinic cholinergic stimulation.
    Sailer M; Oppitz M; Drews U
    Anat Embryol (Berl); 2000 Jan; 201(1):27-37. PubMed ID: 10603091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors.
    Buchli R; Ndoye A; Rodriguez JG; Zia S; Webber RJ; Grando SA
    J Cell Biochem; 1999 Aug; 74(2):264-77. PubMed ID: 10404395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists.
    Qu J; Zhou X; Xie R; Zhang L; Hu D; Li H; Lu F
    Curr Eye Res; 2006; 31(7-8):587-97. PubMed ID: 16877267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of the muscarinic receptor M3 in the human keratinocyte cell line HaCaT.
    Metzger M; Just L; Boss A; Drews U
    Cells Tissues Organs; 2005; 180(2):96-105. PubMed ID: 16113538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of muscarinic receptor subtype M3 in melanomas and their metastases.
    Oppitz M; Busch C; Garbe C; Drews U
    J Cutan Pathol; 2008 Sep; 35(9):809-15. PubMed ID: 18422974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
    Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
    Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells express functional receptors for thyroid-stimulating hormone.
    Ellerhorst JA; Sendi-Naderi A; Johnson MK; Cooke CP; Dang SM; Diwan AH
    Endocr Relat Cancer; 2006 Dec; 13(4):1269-77. PubMed ID: 17158770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro.
    Wach F; Eyrich AM; Wustrow T; Krieg T; Hein R
    J Dermatol Sci; 1996 Jun; 12(2):118-26. PubMed ID: 8814543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin enhancement of directed migration of B16 melanoma cells.
    Lacovara J; Cramer EB; Quigley JP
    Cancer Res; 1984 Apr; 44(4):1657-63. PubMed ID: 6704972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells.
    Choi HJ; Choi YH; Yee SB; Im E; Jung JH; Kim ND
    Mol Carcinog; 2005 Nov; 44(3):162-73. PubMed ID: 16163705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and pharmacological characterization of muscarinic receptors in retinal pigment epithelium: role in light-adaptive pigment movements.
    Phatarpekar PV; Durdan SF; Copeland CM; Crittenden EL; Neece JD; García DM
    J Neurochem; 2005 Dec; 95(5):1504-20. PubMed ID: 16269010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
    Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ
    Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor.
    Tyagi S; Tyagi P; Van-le S; Yoshimura N; Chancellor MB; de Miguel F
    J Urol; 2006 Oct; 176(4 Pt 1):1673-8. PubMed ID: 16952712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Cabadak H; Küçükibrahimoğlu E; Aydin B; Kan B; Zafer Gören M
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):109-15. PubMed ID: 19364336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.